Response Biomedical Q2 FY14: net income $288K; diluted EPS $0.04

Key figures from this report

These are the numbers Response Biomedical reported for Q2 FY14, the quarter ended Jun 30, 2014, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

1. Net income$288KNo year-earlier figure tagged10-Q income statement, on EDGAR
2. Diluted EPS$0.04No year-earlier figure tagged10-Q income statement, on EDGAR
3. Cash and cash equivalents$2.6MNo year-earlier figure tagged10-Q balance sheet, on EDGAR
4. Cash from operations−$1.3MNo year-earlier figure tagged10-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters